128 related articles for article (PubMed ID: 14573766)
1. The peptide KLVFF-K(6) promotes beta-amyloid(1-40) protofibril growth by association but does not alter protofibril effects on cellular reduction of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT).
Moss MA; Nichols MR; Reed DK; Hoh JH; Rosenberry TL
Mol Pharmacol; 2003 Nov; 64(5):1160-8. PubMed ID: 14573766
[TBL] [Abstract][Full Text] [Related]
2. Nordihydroguaiaretic acid does not disaggregate beta-amyloid(1-40) protofibrils but does inhibit growth arising from direct protofibril association.
Moss MA; Varvel NH; Nichols MR; Reed DK; Rosenberry TL
Mol Pharmacol; 2004 Sep; 66(3):592-600. PubMed ID: 15322251
[TBL] [Abstract][Full Text] [Related]
3. Docosahexaenoic acid stabilizes soluble amyloid-beta protofibrils and sustains amyloid-beta-induced neurotoxicity in vitro.
Johansson AS; Garlind A; Berglind-Dehlin F; Karlsson G; Edwards K; Gellerfors P; Ekholm-Pettersson F; Palmblad J; Lannfelt L
FEBS J; 2007 Feb; 274(4):990-1000. PubMed ID: 17227385
[TBL] [Abstract][Full Text] [Related]
4. Branched KLVFF tetramers strongly potentiate inhibition of beta-amyloid aggregation.
Chafekar SM; Malda H; Merkx M; Meijer EW; Viertl D; Lashuel HA; Baas F; Scheper W
Chembiochem; 2007 Oct; 8(15):1857-64. PubMed ID: 17763487
[TBL] [Abstract][Full Text] [Related]
5. Growth of beta-amyloid(1-40) protofibrils by monomer elongation and lateral association. Characterization of distinct products by light scattering and atomic force microscopy.
Nichols MR; Moss MA; Reed DK; Lin WL; Mukhopadhyay R; Hoh JH; Rosenberry TL
Biochemistry; 2002 May; 41(19):6115-27. PubMed ID: 11994007
[TBL] [Abstract][Full Text] [Related]
6. Mechanism of formation of amyloid protofibrils of barstar from soluble oligomers: evidence for multiple steps and lateral association coupled to conformational conversion.
Kumar S; Mohanty SK; Udgaonkar JB
J Mol Biol; 2007 Apr; 367(4):1186-204. PubMed ID: 17292913
[TBL] [Abstract][Full Text] [Related]
7. Assembly of A beta amyloid protofibrils: an in vitro model for a possible early event in Alzheimer's disease.
Harper JD; Wong SS; Lieber CM; Lansbury PT
Biochemistry; 1999 Jul; 38(28):8972-80. PubMed ID: 10413470
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and evaluation of ferrocenoyl pentapeptide (Fc-KLVFF) as an inhibitor of Alzheimer's Aβ₁-₄₂ fibril formation in vitro.
Wei CW; Peng Y; Zhang L; Huang Q; Cheng M; Liu YN; Li J
Bioorg Med Chem Lett; 2011 Oct; 21(19):5818-21. PubMed ID: 21855336
[TBL] [Abstract][Full Text] [Related]
9. Physiochemical characterization of the Alzheimer's disease-related peptides A beta 1-42Arctic and A beta 1-42wt.
Johansson AS; Berglind-Dehlin F; Karlsson G; Edwards K; Gellerfors P; Lannfelt L
FEBS J; 2006 Jun; 273(12):2618-30. PubMed ID: 16817891
[TBL] [Abstract][Full Text] [Related]
10. Design of peptidyl compounds that affect beta-amyloid aggregation: importance of surface tension and context.
Gibson TJ; Murphy RM
Biochemistry; 2005 Jun; 44(24):8898-907. PubMed ID: 15952797
[TBL] [Abstract][Full Text] [Related]
11. Conformational conversion may precede or follow aggregate elongation on alternative pathways of amyloid protofibril formation.
Kumar S; Udgaonkar JB
J Mol Biol; 2009 Jan; 385(4):1266-76. PubMed ID: 19063899
[TBL] [Abstract][Full Text] [Related]
12. Design of peptides that form amyloid-like fibrils capturing amyloid beta1-42 peptides.
Sato J; Takahashi T; Oshima H; Matsumura S; Mihara H
Chemistry; 2007; 13(27):7745-52. PubMed ID: 17605154
[TBL] [Abstract][Full Text] [Related]
13. Formation of toxic Abeta(1-40) fibrils on GM1 ganglioside-containing membranes mimicking lipid rafts: polymorphisms in Abeta(1-40) fibrils.
Okada T; Ikeda K; Wakabayashi M; Ogawa M; Matsuzaki K
J Mol Biol; 2008 Oct; 382(4):1066-74. PubMed ID: 18692507
[TBL] [Abstract][Full Text] [Related]
14. Peptide and protein mimetics inhibiting amyloid beta-peptide aggregation.
Takahashi T; Mihara H
Acc Chem Res; 2008 Oct; 41(10):1309-18. PubMed ID: 18937396
[TBL] [Abstract][Full Text] [Related]
15. Ex situ atomic force microscopy analysis of beta-amyloid self-assembly and deposition on a synthetic template.
Ha C; Park CB
Langmuir; 2006 Aug; 22(16):6977-85. PubMed ID: 16863248
[TBL] [Abstract][Full Text] [Related]
16. Mechanism of docosahexaenoic acid-induced inhibition of in vitro Abeta1-42 fibrillation and Abeta1-42-induced toxicity in SH-S5Y5 cells.
Hossain S; Hashimoto M; Katakura M; Miwa K; Shimada T; Shido O
J Neurochem; 2009 Oct; 111(2):568-79. PubMed ID: 19686246
[TBL] [Abstract][Full Text] [Related]
17. Amyloid-beta(1-42) rapidly forms protofibrils and oligomers by distinct pathways in low concentrations of sodium dodecylsulfate.
Rangachari V; Moore BD; Reed DK; Sonoda LK; Bridges AW; Conboy E; Hartigan D; Rosenberry TL
Biochemistry; 2007 Oct; 46(43):12451-62. PubMed ID: 17910477
[TBL] [Abstract][Full Text] [Related]
18. Recognition sequence design for peptidyl modulators of beta-amyloid aggregation and toxicity.
Pallitto MM; Ghanta J; Heinzelman P; Kiessling LL; Murphy RM
Biochemistry; 1999 Mar; 38(12):3570-8. PubMed ID: 10090743
[TBL] [Abstract][Full Text] [Related]
19. Unique physicochemical profile of beta-amyloid peptide variant Abeta1-40E22G protofibrils: conceivable neuropathogen in arctic mutant carriers.
Päiviö A; Jarvet J; Gräslund A; Lannfelt L; Westlind-Danielsson A
J Mol Biol; 2004 May; 339(1):145-59. PubMed ID: 15123427
[TBL] [Abstract][Full Text] [Related]
20. Hsp104 targets multiple intermediates on the amyloid pathway and suppresses the seeding capacity of Abeta fibrils and protofibrils.
Arimon M; Grimminger V; Sanz F; Lashuel HA
J Mol Biol; 2008 Dec; 384(5):1157-73. PubMed ID: 18851977
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
